Biogen Idec Management Discusses Q3 2012 Results – Earnings Call Transcript – Seeking Alpha

Biogen Idec Management Discusses Q3 2012 Results – Earnings Call Transcript
Seeking Alpha
We're continuing to do exploratory work in allergic asthma as a possible indication for the lead molecule and are focusing on additional 6 selective backup compounds for what we believe is a key pathway in chronic autoimmune and inflammatory diseases

and more »

View full post on world asthma day – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *